FUNDED GRANTS

SEARCH GRANTS

FROM

TO

YEAR FUNDED

LOCATION

INSTITUTION

RESEARCHER

FILTERS:

From: 2000

clinical discovery awards

The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.

FUNDED GRANTS (
12)

NeuroDerm Ltd. is developing a novel delivery system of levodopa for the treatment of Parkinson's disease. Levodopa, a well-established medication for the treatment of Parkinson's disease (PD), is considered the most effective treatment of PD. However, when given orally, it is eliminated from the body very quickly. This results in cycles of sharp fluctuations of its concentration in the blood. It ...

The etiology of Parkinson's disease is unknown although previous research has implicated environmental factors in most cases. We have previously shown that welding, an occupation performed by over 500,000 workers in the United States, may increase the risk of parkinsonism. These studies require confirmation in a rigorously designed study. The purpose of this grant is to determine whether occupatio...

Genes play a significant role in the risk of developing Parkinson's disease. Some genes have already been identified, but several others remain to be identified. One way to find these genes is to study very large families that come from unique human populations. We have identified and collected part of a very large family with PD in the Amish, who are both culturally and genetically separate from ...

Falls are common and disabling in people with Parkinson's disease, affecting up to 60% of those who live at home. This clinical research trial aims to minimize the number of falls and fall-related injuries in people with Parkinson's disease and to improve mobility and participation in life. Two physical therapy programs, known as movement strategy training and strength training will be coupled wit...

Parkinson's disease (PD) is related to abnormal functioning of an area of the brain known as the basal ganglia. A model of how the basal ganglia works, known as the rate model, proposed about 15 years ago, has led to new surgical treatment for PD and other movement disorders. However, there is emerging evidence that the model is inadequate. A new model, known as the oscillation model of the basal ...